Cancer and embolic stroke of undetermined source
One-quarter to one-third of ischemic strokes have no established mechanism after standard
diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS) …
diagnostic evaluation and are classified as embolic stroke of undetermined source (ESUS) …
Ischemic stroke in cancer patients: a review of an underappreciated pathology
BB Navi, C Iadecola - Annals of neurology, 2018 - Wiley Online Library
Currently 1 in 10 patients with ischemic stroke have comorbid cancer, and this frequency is
expected to increase with continued advances in cancer therapeutics prolonging median …
expected to increase with continued advances in cancer therapeutics prolonging median …
[HTML][HTML] Cancer-related stroke: an emerging subtype of ischemic stroke with unique pathomechanisms
Systemic cancer and ischemic stroke are common conditions and two of the most frequent
causes of death among the elderly. The association between cancer and stroke has been …
causes of death among the elderly. The association between cancer and stroke has been …
Clinical outcome after endovascular treatment in patients with active cancer and ischemic stroke: a MR CLEAN registry substudy
MA Verschoof, AE Groot, SFTM de Bruijn… - Neurology, 2022 - AAN Enterprises
Background and Objectives To explore clinical and safety outcomes of patients with acute
ischemic stroke (AIS) and active cancer after endovascular treatment (EVT). Methods Using …
ischemic stroke (AIS) and active cancer after endovascular treatment (EVT). Methods Using …
Histological features of intracranial thrombi in stroke patients with cancer
H Park, J Kim, J Ha, IG Hwang, TJ Song… - Annals of …, 2019 - Wiley Online Library
The histological features of thrombus in stroke patients with cancer are not well known.
Using immunohistochemical staining of thrombi retrieved during mechanical thrombectomy …
Using immunohistochemical staining of thrombi retrieved during mechanical thrombectomy …
[HTML][HTML] Ischemic stroke: a paradoxical manifestation of cancer
RA Salazar-Camelo, EA Moreno-Vargas… - Critical Reviews in …, 2021 - Elsevier
Abstract Introduction Approximately 5–10% of the patients with cryptogenic stroke have an
underlying malignancy. Stroke as a complication of cancer increases the morbidity and …
underlying malignancy. Stroke as a complication of cancer increases the morbidity and …
Cancer and stroke: what do we know and where do we go?
Cancer is an increasingly recognized cause for ischemic stroke, with recent
acknowledgement of cancer-related stroke as an emerging stroke subtype with unique …
acknowledgement of cancer-related stroke as an emerging stroke subtype with unique …
[HTML][HTML] Ischemic stroke with cancer: hematologic and embolic biomarkers and clinical outcomes
Background Patients with cancer and acute ischemic stroke (AIS) face high rates of recurrent
thromboembolism or death. Objectives To examine whether hematologic and embolic …
thromboembolism or death. Objectives To examine whether hematologic and embolic …
Immediate and long-term outcomes of reperfusion therapy in patients with cancer
Background and Purpose: Patients with acute stroke are often accompanied by
comorbidities, such as active cancer. However, adequate treatment guidelines are not …
comorbidities, such as active cancer. However, adequate treatment guidelines are not …
Intra-arterial thrombectomy for acute ischaemic stroke patients with active cancer
Background and purpose This study aimed to evaluate the efficacy of intra-arterial
thrombectomy (IAT) and prognosis for acute ischaemic stroke patients with active cancer …
thrombectomy (IAT) and prognosis for acute ischaemic stroke patients with active cancer …